HomeKLRS • NASDAQ
add
Kalaris Therapeutics Inc
Previous close
$6.12
Day range
$5.69 - $6.16
Year range
$2.14 - $11.88
Market cap
133.33M USD
Avg Volume
61.37K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
The Globe and Mail
23 minutes ago
Should You Buy the 3 Highest-Yielding Dividend Stocks in the Nasdaq?
0.048%
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 10.80M | 51.42% |
Net income | -10.00M | 54.61% |
Net profit margin | — | — |
Earnings per share | -0.44 | — |
EBITDA | -10.79M | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 117.98M | 7,098.41% |
Total assets | 121.74M | 1,875.59% |
Total liabilities | 42.92M | -24.41% |
Total equity | 78.81M | — |
Shares outstanding | 22.93M | — |
Price to book | 1.78 | — |
Return on assets | -26.61% | — |
Return on capital | -43.67% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -10.00M | 54.61% |
Cash from operations | -7.06M | 10.11% |
Cash from investing | 14.98M | — |
Cash from financing | 47.74M | 530.06% |
Net change in cash | 55.67M | 20,416.06% |
Free cash flow | -2.36M | -129.44% |
About
Founded
2019
Headquarters
Website
Employees
20
